Happy And Safe Diwali: How Smoke From Firecrackers Puts Children's Vision At Risk
Diwali is the time of the year when our nation’s children are on holiday and festivities are rampant. Sadly this fun time for children is also when firecrackers and fireworks are available in plenty. The word “firecrackers” evokes quite a bit of emotion and is often associated with great joy but one must realize that the chemical smoke and gases released from firecrackers can be regarded as a serious concern for the capacity of eyes for children.
It is shocking to know that mothers and fathers have been using firecrackers for this long despite it being scientifically proven to be a pollutant and one that can heavily damage children’s eyesight.
But now, as a parent, most people see things differently—firecracker smoke, while dazzling, risks young eyes and health. From choosing eco-friendly lights and indoor activities, ensuring a festive, safe celebration for your children’s well-being is important and necessary. Dr. Neeraj Sanduja, MBBS, MS - Ophthalmology, Ophthalmologist, Eye Surgeon shares all about the toxic effects of smoke from the firecrackers kids so lovingly enjoy bursting and how harmful they can be for their eyes.
The smoke from firecrackers is a blend of toxic chemicals and fine particles, each carrying potential harm for the delicate tissues of the eyes. Here are some key pollutants present in firecracker smoke that pose specific dangers:
Particulate matter: These are the fumes exhaled from burning that are extremely small but can infiltrate deep into the lungs and eyes creating lesions and scars.
Sulfur dioxide & nitrogen oxides: These gasses emit acid rain, it's easy to comprehend how detrimental it is to the human body.
Heavy metals: If consumed through the skin lead arsenic or any other toxic metals emitted through firecrackers will inflict great damage.
Exposure to firecracker smoke can cause a range of immediate symptoms in children, as well as chronic eye problems that may not become apparent until much later. Children are at high risk of developing some symptoms upon exposure to firecracker smoke, and these include:
Red eye syndrome: Clinical eye examinations show that the eyes can be red and watery, as well as itchy due to the smoke's chemicals.
Eye pain: Another common complaint in children is a burning and stinging sensation in the eye areas.
Intolerance to light: The burning of firecrackers leads to the emission of smoke that can irritate the eyes and increase their sensitivity.
Corneal damage: Severe inflammation of the outer layer of the eyeball caused by exposure to smoke may be a more damaging injury caused than previously mentioned damages of the inner layer.
While some eye issues may appear right after exposure, others may develop subtly and manifest over time, resulting in chronic eye conditions. Dr Neeraj exclaims, "Of great concern is the fact that parents may not notice these initial signs and the signs that are causes are others since these are only some of the diseases that are dangerous but children who continuously come into contact with air polluted by firecrackers may consider the following risks:
Parents can observe the following measures to shield their children's eyes from the harmful effects of firecracker smoke:
Avoid exposure: In the first place, the best way to avoid damaging children’s eyes is to prevent any contact with firecracker smoke. Encourage children to remain in the house or in well-ventilated areas during a firework display.
Wear protective eyewear: In the event that children have to go outside during a firework display, they should wear protective eyewear such as goggles or sunglasses.
Rinse eyes thoroughly: In case of exposure of firework smoke to the child’s eyes, the affected eyes should be washed with plenty of clean water.
Seek medical attention: If a child suffers from intense pain in the eyes, redness in the eyes or any changes in vision after exposure to cracker smoke, he/she should be taken to a medical facility as soon as possible.
1. Educate Children on Firecracker Safety
2. Monitor Air Quality Index (AQI)
3. Plan Indoor Activities During Peak Pollution Hours
4. Encourage Healthy Eye Habits (Regular Exams, Hygiene)
1. Eco-Friendly Firecrackers
2. Laser Light Shows
3. Community Events (Parades, Festivals)
4. Indoor Games and Activities
5. Environmentally Conscious Celebrations
Firecrackers undoubtedly liven up the festivities; however, the use of firecrackers and their impact on the health of children has caused a lot of concern, especially their vision. It has become crucial to protect young developing eyes from fire cracker pollution which is harmful to them, especially in the long run. In this manner, we are able to assist in the preservation of our children’s eyesight and create safe and happy festive occasions for everyone.
Credits: Canva
A newly recognised form of diabetes is reshaping how scientists and doctors view the condition, particularly in countries like India. In 2025, global health authorities officially acknowledged Type 5 diabetes as a separate and distinct form of the disease.
This recognition ended decades of confusion around a type of diabetes that did not fit neatly into the existing categories of Type 1 or Type 2 diabetes. The formal classification, backed by the International Diabetes Federation and supported by research published in The Lancet Global Health, is expected to transform diagnosis, treatment, and long-term care for millions of people worldwide.
But what exactly is Type 5 diabetes, and how does it differ from the types of diabetes that are more widely known?
Type 5 diabetes is now recognised as a distinct form of the disease caused primarily by severe, long-term malnutrition, often experienced during childhood. This undernutrition can lead to profound insulin deficiency and an underdeveloped pancreas, resulting in significantly reduced insulin production.
Unlike Type 1 diabetes, which is autoimmune, or Type 2 diabetes, which is linked to insulin resistance, Type 5 diabetes arises from nutritional deficiencies that impair the pancreas’s ability to function properly.
It most commonly affects lean young adults in low-income regions. For years, people with this condition were misdiagnosed as having Type 1 diabetes or an unusual form of Type 2, often leading to inappropriate treatments that failed to address the root cause.
Symptoms of type 5 diabetes can resemble those seen in other forms of diabetes, such as excessive thirst, frequent urination, persistent tiredness, unexplained weight loss, blurred vision, and slow-healing wounds. However, they are often paired with indications of malnutrition, including a lean physique, delayed growth or puberty in young people, anemia, and recurring infections.
These arise from nutritional deficiencies during early life rather than solely from insulin resistance or autoimmune causes, and they usually present before the age of 30, according to the International Diabetes Federation.
Researchers have been studying this condition for decades, particularly in parts of Asia and Africa. Yet, without official recognition, the disease remained poorly understood, and patients were rarely diagnosed correctly. Experts argued that grouping these patients under existing categories obscured the true cause of their illness.
The 2025 classification now formally separates Type 5 diabetes from other types, making it easier to study, identify, and manage. In India, where diabetes prevalence is already high, this recognition is particularly relevant. Tens of millions of people live with diabetes in the country, many of whom remain undiagnosed. Type 5 diabetes highlights a different pattern: it develops not from excess calories, but from too little nutrition during childhood, creating a double burden in regions where obesity and undernutrition coexist.
Although there is no new treatment specifically for Type 5 diabetes yet, official recognition marks a major step forward. Doctors can now approach lean patients with a history of malnutrition more carefully, avoiding a “one-size-fits-all” approach. Clearer classification could lead to better guidelines, more personalised care, fewer complications, and improved long-term outcomes.
Experts believe that understanding the role of childhood undernutrition in diabetes could eventually reshape how we prevent, monitor, and manage the condition—something countries like India urgently need as diabetes numbers continue to rise.
Credits: Canva
An early sign of dementia can sometimes look like a common winter-related issue. When this symptom appears along with other warning signals, it may be wise to speak to a doctor. Dementia is a syndrome marked by a collection of related symptoms that point to a gradual decline in brain function. Over time, this can affect memory, behaviour, thinking, and even movement. In its early phase, however, dementia often shows up through subtle changes that are easy to overlook or mistake for something less serious.
Dementia UK notes that one possible early indicator of dementia is “low mood, anxiety or depression”. Its specialists explain: “In the early stages of dementia, people often begin to notice symptoms that interfere with day-to-day life.” The difficulty is that low mood or depression can also be linked to seasonal affective disorder (SAD), a form of depression that tends to appear during winter and ease as the days become longer and brighter.
The NHS lists the following possible symptoms of SAD:
The organisation explains: “A person experiencing early symptoms of dementia may notice these changes themselves, or they may be picked up first by family members, friends or colleagues. Memory problems are not always obvious in the early stages of some types of dementia, such as frontotemporal dementia, where changes in behaviour and personality may appear first.
“People with young onset dementia, where symptoms begin before the age of 65, are also less likely to have memory loss as an early symptom.”
The charity also points out that emotional changes can be linked to two specific types of dementia. In vascular dementia, a person may experience “changes in mood, behaviour and personality”, while Lewy body dementia can cause “mood changes, including anxiety and depression”.
That said, it is often difficult to know at first whether dementia is the cause of these warning signs. Dementia UK advises: “Many symptoms associated with dementia can also be caused by other physical or mental health conditions, such as thyroid disorders, menopause, vitamin B12 deficiency, depression, anxiety, work-related stress or relationship difficulties.
“This means that experiencing symptoms linked to dementia does not automatically mean someone has the condition. However, if you or someone close to you is showing signs or symptoms of dementia, it is important to visit a GP to understand what might be causing them.”
If you or someone you know is showing symptoms that resemble dementia, seeking advice from your GP is an important first step.
Credits: Canva
Gonorrhea poses a far more serious challenge than many realise. Over the years, doctors treating the infection have seen their treatment choices steadily shrink. The bacteria responsible, Neisseria gonorrhoeae, has repeatedly adapted to antibiotics, rendering many once-reliable drugs ineffective. As a result, clinicians have been forced to depend heavily on a single injectable medication, a situation that has raised growing concern.
That dependence is becoming increasingly risky. Data from the US Centers for Disease Control and Prevention show that reported cases of gonorrhea, chlamydia, and syphilis have climbed by nearly 90% since 2004. In 2023 alone, the country recorded more than 2.4 million cases of sexually transmitted infections.
This month, however, marked a significant shift. The US Food and Drug Administration approved two new oral antibiotics to treat gonorrhea: zoliflodacin and gepotidacin. These approvals represent the first entirely new gonorrhea treatments in more than three decades.
“These approvals mark a significant milestone for treatment options for patients with uncomplicated urogenital gonorrhea,” said Dr Adam Sherwat of the FDA in an official statement.
If left untreated, gonorrhea can lead to serious complications, including pelvic inflammatory disease, infertility, and in rare cases, infections that spread to the joints or bloodstream, as per Cleveland Clinic. Many people experience no symptoms at all, allowing the infection to spread quietly. Despite years of research, there is still no licensed vaccine, leaving antibiotics as the primary line of defence.
The newly approved treatments offer a fresh sense of hope. Zoliflodacin, developed by the nonprofit Global Antibiotic Research and Development Partnership in collaboration with Innoviva Specialty Therapeutics, is designed as a single-dose oral medication. Gepotidacin, developed by GSK, is taken in two doses and is also approved for treating certain urinary tract infections.
Both medicines eliminate the need for injections, a shift that could make treatment simpler and more accessible, particularly in settings where access to clinics is limited.
As per Medscape, clinical trial results for both drugs have been encouraging. Zoliflodacin was tested in a large international study involving more than 900 participants across Europe, Africa, Asia, and the US. The drug successfully cured about 90.9% of patients, a rate comparable to the 96.2% success rate of the current injectable standard. Most reported side effects were mild.
Gepotidacin showed similarly strong results in a separate Phase 3 trial that included around 600 patients from six countries. The cure rate reached 92.6%. Some participants reported digestive issues, but these effects were generally described as mild.
Importantly, both medications were effective against strains of gonorrhea that no longer respond to older antibiotics. That said, public health experts stress that these drugs are not a permanent solution.
“Bacteria are smart. They can pass resistant mechanisms between each other,” said Dr Manica Balasegaram of the Global Antibiotic Research and Development Partnership, speaking to CNN.
Several uncertainties remain. Neither drug has yet shown strong effectiveness against throat infections, known as pharyngeal gonorrhea, which are more difficult to detect and treat. There is also ongoing debate about how best to use the new medications. Some experts argue they should be reserved as last-line treatments, while others believe earlier use could help slow resistance.
Dr Tereza Kasaeva of the World Health Organization described the approvals as “an important and timely development” amid rising global infection rates and limited treatment options, according to The Guardian.
For now, the new drugs provide much-needed breathing room. Whether that progress holds will depend on careful prescribing and close monitoring of how resistance evolves.
© 2024 Bennett, Coleman & Company Limited